Becoming a substantial holder
January 30, 2019
Form 603, “Notice of initial substantial holder” was lodged with the Australian Securities Exchange on 30th January at 5:29 PM. View the form 603.
Category: Investor updates
Becoming a substantial holder
January 30, 2019
Form 603, “Notice of initial substantial holder” was lodged with the Australian Securities Exchange on 30th January at 5:25 PM. View the Form 603.
Imagion Biosystems teams with Planet Innovation for MagSense® Instrument Development
December 17, 2018
MELBOURNE, Australia, Dec. 17, 2018 /PRNewswire/ — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Planet
Cleansing Notice
November 28, 2018
Imagion Biosystems Limited (ASX: IBX) has lodged “Notice Pursuant to Section 708A(5)(e) of the Corporations Act” with the Australian Securities Exchange. View Notice Pursuant to Section
Appendix 3B New Issue Announcement
November 28, 2018
Imagion Biosystems Limited (ASX: IBX) has lodged “Appendix 3B: New issue announcement, application for quotation of additional securities and agreement” with the Australian Securities Exchange.
Imagion Biosystems Raises $4.3M Via Rights Issue
November 19, 2018
Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce that it
Proactiveinvestors Interviews Bob Proulx
November 9, 2018
Proactiveinvestors news media have interviewed Imagion Biosystems CEO Bob Proulx, who answers questions about the company’s early cancer detection technology, its place in the the
IBX Appendix 4C — September 2018 Quarterly Update
October 31, 2018
Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to provide an update on its activities
Appendix 3Y — Change of Director's Interest Notice
October 30, 2018
The announcement “Appendix 3Y — Change of Director’s Interest Notice” has been lodged with the Australian Securities Exchange. Read Appendix 3Y — Change of Director’s
Despatch of Rights Issue Offer Documents
October 3, 2018
Imagion Biosystems has lodged the announcement “Despatch of Rights Issue Offer Documents” with the Australian Securities Exchange. View Despatch of Rights Issue Offer Documents.